Clinical Trial Update: Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a paclitaxel-eluting covered metallic stent for unresectable malignant bile duct obstruction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Obstruction

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Paclitaxel-eluting covered metallic stent

Snippet

Sponsor: Asan Medical Center | Conditions: Bile Duct Obstruction | Phase 3 | Status: COMPLETED